Corneas harvested from patients who died of drowning are viable for transplantation

News
Article

Postoperative outcomes of the tissues obtained from these donors were satisfactory

A doctor reviews paperwork with a woman. Image credit: ©Drazen – stock.adobe.com

Details of the quality of the corneal tissue and the outcomes after the corneal transplantations were collected from the eye bank and outpatient records. Image credit: ©Drazen – stock.adobe.com

Donor corneas obtained from individuals who drowned are safe for transplantation,1 according to researchers from the Cornea and Anterior Segment Service, L V Prasad Eye Institute, Bhubaneswar, Odisha, India.

Kshyanaprava Priyadarshini, MS, first author of the study, described the retrospective investigation that led to this result. The aim of this study, she recounted, was to analyse the tissue quality and outcomes of corneal transplantations from donor corneal tissues harvested from drowning victims from March 2018 to September 2022. The details of the quality of the corneal tissue and the outcomes after the corneal transplantations were collected from the eye bank and outpatient records.

Over the course of the study, 34 donor corneas were obtained from drowning victims who were a mean age of 37.1 ± 20.3 years. The mean time from when the tissue was obtained to its preservation was 4.9 ± 2.6 hours.

The mean endothelial cell density of the donor corneas was 3,025 ± 271 cells/mm2. Of the 34 corneas, 20 (58.8%) were transplanted at the L V Prasad Eye Institute, 2 were stored in glycerol for future use, and 12 were transported to other transplantation centers. Overall, 94.1% or 32 corneas were transplanted.

Of the 20 corneas used at the L V Prasad Eye Institute, 17 were used for optical grafts and 3 for therapeutic indications, according to Ms Priyadarshini. Of the 17 optical grafts, 10 were used for optical penetrating keratoplasty, 6 for endothelial keratoplasty and 1 for anterior lamellar keratoplasty. The most common indication for keratoplasty was regrafting because of a previously failed graft (25%), she reported. No infections developed in any of the transplanted eyes during the immediate postoperative period. Eight eyes had clear grafts after 3 months.

Of the 12 tissues transferred to other keratoplasty centers, 10 were used for optical grafts and 2 for therapeutic/tectonic grafts.

The researchers concluded, “Donor corneas retrieved from drowning victims may be considered safe for transplantation. The postoperative outcomes of the tissues obtained from these donors were satisfactory. Hence, these donor corneas can be optimally used in routine transplantation procedures.”

Reference

1. PriyadarshiniK,Das S, Sahu SK, et al. Safety and efficacy profile of corneas harvested from donors of drowning victims. Cornea. 2024;43:141-145; doi: 10.1097/ICO.0000000000003321

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.